Encephalopathy under systemic high-dose methotrexate therapy in acute lymphoblastic leukemia;Enzephalopathie unter systemischer hochdosis-methotrexattherapie bei akuter lymphoblastischer leukamie

Monatsschrift fur Kinderheilkunde

Volumn 148, Issue 1, 2000, Pages 13-17

  Eisberg, Stefanie ^a   Tillmann, W ^b  

^a NONE   (Germany)

^b NONE

Author keywords

Adenosine; Homocysteine; Methotrexate encephalopathy; Neurotoxicity; Tetrahydrobiopterine

Indexed keywords

ADENOSINE; BETAINE; BIOPTERIN; FOLINIC ACID; HOMOCYSTEINE; METHOTREXATE; PYRIDOXINE; TETRAHYDROBIOPTERIN; THEOPHYLLINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN DISEASE; CASE REPORT; CHEMICAL REACTION; CHILD; FOLATE METABOLISM; HUMAN; METABOLIC DISORDER; NEUROTOXICITY; REACTION ANALYSIS;

EID: 0034066281     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001120050003     Document Type: Article

References (24)

1. Allegra CJ, Drake JC, Jolivet J, Chabner BA (1985) Inhibition of phosphoribosyl-amino-imidazole-carboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. Proc Natl Acad Sci USA 82:4881-4885
2. Bernini JC, Fort DW, Griener JC, Kane DJ, Chappell WB, Kamen BA (1995) Aminophylline for methotrexate-induced neurotoxicity. Lancet 345:544-547
3. Blau N, Curtius HC, Kierat L, Leupold D, Kohne E (1989) Hyperphenylalaninemia caused by dihydropteridine reductase defciency in children receiving chemotherapy for acute lymphoblastic leukemia. J Pediatr 115:661-662
4. Botez MI, Young SN, Bachevalier J, Gauthier S (1979) Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature 278:182-183
5. Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MWP, Toone BK, Reynolds EH (1992) Folate deficiency, biopterine and monoamine metabolism in depression. Psychol Med 22:871-876
6. Broxson EH, Stork LC, Allen RH, Stabler SP, Kolhouse JF (1989) Changes in plasma methionine and total homo-cysteine levels in patients receiving methotrexate infusions. Cancer Res 49:5879-5883
7. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, De Garmo P (1990) Elevated plasma homocysteine concentration as a possible independent risk factor for stroke. Stroke 21:572-576
8. Cronstein BN, Eberle MA, Gruber HE, Levin RI (1991) Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 88:2441-2445
9. Cronstein BN, Naime D, Ostad E (1993) The anti-inflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 92:2675-2682
10. Culvenor AJ, Miller LP, Levine RA, Lovenberg W (1984) Effects of methotrexate on biopterine levels and synthesis in rat cultured pineal glands. J Neurochem 42:1707-1714
11. Duch DS, Lee CL, Edelstein MP, Nichol CA (1983) Biosynthesis of tetrahydrobiopterine in the presence of dihydrofolate reductase inhibitors. Mol Pharmacol 24:103-108
12. Gilbert MR, Harding BL, Grossman SA (1989) Methotrexate neurotoxicity in vitro studies using cerebellar explants from rats. Cancer Res 49:2502-2505
13. Hum ML, Smith AK, Lark RH, Winich NJ, Kamen BA (1997) Evidence for negative feedback of extracellular methotrexate on blasts of acute lymphoblastic leukemia in vitro. Pharmacotherapy 17:1260-1266
14. Hyland K, Smith I, Bottiglieri T, Petty J, Wendel U, Clayton PT, Leonard JV (1988) Demyelination and decreased 5-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology 38:459-462
15. Johnston MV, Silverstein FS, Greenberg H, Knutsen CA, Chandler W, Phillips T, Ensminger WD (1986) Effects of intraventricular methotrexate on cerebrospinal fluid monoamine metabolism in rhesus monkeys. Cancer Treat Rep 70:1205-1209
16. Kamen BA, Winick HJ (1988) High-dose methotrexate therapy: insecure rationale? Biochem Pharmacol 37:2713-2715
17. Mason JB, Miller JW (1992) The effects of vitamins B 12, B 6 and folate on blood homocysteine levels. Ann NY Acad Sci 669:197-204
18. Millot F, Chastagner P, Dhondt J, Sommelet D (1992) Substitutive therapy in a case of methotrexate neurotoxicity. Eur J Cancer 28A:1935
19. 2 intravenous methotrexate. Pediatr Res 37:151-154
20. Quinn CT, Griener JC, Bottiglieri T, Hyland K, Farrow A, Kamen BA (1997) Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol 15:2800-2806
21. Quinn CT, Kamen BA (1996) A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Invest Med 44:522-530
22. Refsum H, Ueland PM, Kvinnsland S (1986) Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res 46:5879-5883
23. Smith I, Howells DW, Hyland K (1986) Pteridines and monoamines: relevance to neurological damage. Postgrad Med 62:113-123
24. Surtess R, Heales S, Bowron A (1994) Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not 5-adenosylmethionine, with reduced concentration of the acid metabolites of S-hydroxytryptamine and dopamine. Clin Sci (Colch) 86:697-702